The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Epigenetic inactivation to target the arginine biosynthetic pathway in multiple myeloma.
Eleftheria Hatzimichael
No relevant relationships to disclose
Aggeliki Dasoula
No relevant relationships to disclose
Nelofer Syed
No relevant relationships to disclose
Peter Wojciech Szlosarek
No relevant relationships to disclose
George Dranitsaris
No relevant relationships to disclose
Tim Crook
No relevant relationships to disclose
Evangelos C. Briasoulis
No relevant relationships to disclose